Working together, we can reimagine medicine to improve and extend people's lives.

Discovery
Our purpose

Discovery
Our leadership

Discovery
Our therapeutic areas

Our technology

Novartis 2024 Financial Results
Novartis announces the company’s fourth quarter and 2024 full year financial results.

Novartis in Society Integrated Report 2024
Read more about our performance against our business, environmental, social and governance (ESG) priorities in the Novartis in Society Integrated Report 2024.
Latest news
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with SMA
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2025 Annual General Meeting
Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

Official partner of the Eurovision Song Contest 2025
Between May 10-17, 2025, Basel will host the Eurovision Song Contest and we are excited to be an official partner.